171 related articles for article (PubMed ID: 27449474)
1. Tuning structural parameters for the optimization of drug delivery performance of cyclodextrin-based nanosponges.
Venuti V; Rossi B; Mele A; Melone L; Punta C; Majolino D; Masciovecchio C; Caldera F; Trotta F
Expert Opin Drug Deliv; 2017 Mar; 14(3):331-340. PubMed ID: 27449474
[TBL] [Abstract][Full Text] [Related]
2. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Cyclodextrin Nanosponges.
Caldera F; Tannous M; Cavalli R; Zanetti M; Trotta F
Int J Pharm; 2017 Oct; 531(2):470-479. PubMed ID: 28645630
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
5. Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics.
Pyrak B; Rogacka-Pyrak K; Gubica T; Szeleszczuk Ł
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542499
[TBL] [Abstract][Full Text] [Related]
6. Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study.
Ferro M; Castiglione F; Punta C; Melone L; Panzeri W; Rossi B; Trotta F; Mele A
J Vis Exp; 2016 Aug; (114):. PubMed ID: 27585291
[TBL] [Abstract][Full Text] [Related]
7. Effect of cross-linking properties on the vibrational dynamics of cyclodextrins-based polymers: an experimental-numerical study.
Castiglione F; Crupi V; Majolino D; Mele A; Rossi B; Trotta F; Venuti V
J Phys Chem B; 2012 Jul; 116(27):7952-8. PubMed ID: 22694243
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.
Chilajwar SV; Pednekar PP; Jadhav KR; Gupta GJ; Kadam VJ
Expert Opin Drug Deliv; 2014 Jan; 11(1):111-20. PubMed ID: 24298891
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-grafted cellulose: physico-chemical characterization.
Medronho B; Andrade R; Vivod V; Ostlund A; Miguel MG; Lindman B; Voncina B; Valente AJ
Carbohydr Polym; 2013 Mar; 93(1):324-30. PubMed ID: 23465937
[TBL] [Abstract][Full Text] [Related]
10. Networking properties of cyclodextrin-based cross-linked polymers probed by inelastic light-scattering experiments.
Rossi B; Caponi S; Castiglione F; Corezzi S; Fontana A; Giarola M; Mariotto G; Mele A; Petrillo C; Trotta F; Viliani G
J Phys Chem B; 2012 May; 116(17):5323-7. PubMed ID: 22497332
[TBL] [Abstract][Full Text] [Related]
11. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
12. The application of nanosponges to cancer drug delivery.
Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based nanosponges as promising carriers for active agents.
Allahyari S; Trotta F; Valizadeh H; Jelvehgari M; Zakeri-Milani P
Expert Opin Drug Deliv; 2019 May; 16(5):467-479. PubMed ID: 30845847
[TBL] [Abstract][Full Text] [Related]
14. Diversity of β-cyclodextrin-based nanosponges for transformation of actives.
Pawar S; Shende P; Trotta F
Int J Pharm; 2019 Jun; 565():333-350. PubMed ID: 31082468
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin/PEG based hydrogels for multi-drug delivery.
Salmaso S; Semenzato A; Bersani S; Matricardi P; Rossi F; Caliceti P
Int J Pharm; 2007 Dec; 345(1-2):42-50. PubMed ID: 17597313
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence of gel-sol transition in cyclodextrin-based hydrogels as revealed by FTIR-ATR spectroscopy.
Crupi V; Majolino D; Mele A; Melone L; Punta C; Rossi B; Toraldo F; Trotta F; Venuti V
Soft Matter; 2014 Apr; 10(13):2320-6. PubMed ID: 24652067
[TBL] [Abstract][Full Text] [Related]
17. Nanosponge Carriers- An Archetype Swing in Cancer Therapy: A Comprehensive Review.
Osmani RA; Hani U; Bhosale RR; Kulkarni PK; Shanmuganathan S
Curr Drug Targets; 2017; 18(1):108-118. PubMed ID: 26424399
[TBL] [Abstract][Full Text] [Related]
18. Supramolecular hydrogels from in situ host-guest inclusion between chemically modified cellulose nanocrystals and cyclodextrin.
Lin N; Dufresne A
Biomacromolecules; 2013 Mar; 14(3):871-80. PubMed ID: 23347071
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention.
Coviello V; Sartini S; Quattrini L; Baraldi C; Gamberini MC; La Motta C
Eur J Pharm Biopharm; 2017 Aug; 117():276-285. PubMed ID: 28456606
[TBL] [Abstract][Full Text] [Related]
20. Drug-Encapsulated Cyclodextrin Nanosponges.
Tannous M; Caldera F; Hoti G; Dianzani U; Cavalli R; Trotta F
Methods Mol Biol; 2021; 2207():247-283. PubMed ID: 33113141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
